Table 4

Cytokine profile of peripheral blood CD3+ T cells in patients with spondyloarthropathy at baseline (day 0) and during treatment with anti-TNF-α (infliximab 5 mg/kg intravenously on days 0, 14, and 42)

  • Results are expressed as median (range).

  • Percentage of positive cells and mean fluorescence intensity (MFI) for interferon (IFN)γ and interleukin (IL)2 were assessed by flow cytometry.

  • 4-150 p⩽0.05,

  • 4-151 p⩽0.01 difference from baseline values.